𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dose related effectiveness of alpha interferon in chronic myelogenous leukemia

✍ Scribed by Gastl, G. ;Aulitzky, Q. ;Tilg, H. ;Huber, H. ;Hausmaninger, H. ;Seewann, H. L. ;Coser, C. ;Prinoth, P. ;Huber, C.

Publisher
Springer-Verlag
Year
1987
Weight
107 KB
Volume
54
Category
Article
ISSN
1432-0584

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Recombinant human interferon-alpha induc
Recombinant human interferon-alpha induced cytoreduction in chronic myelogenous leukemia
✍ Werter, M. ;Witte, R. ;Janssen, J. ;Pauw, B. ;Haanen, C. πŸ“‚ Article πŸ“… 1988 πŸ› Springer-Verlag βš– 365 KB

Fourteen patients with Ph'-chromosome positive chronic myelogenous leukemia (CML) in first chronic phase were treated with recombinant interferon-alpha 2c. Interferon-alpha 2c 5 to 10 X 10(6) units s.c. was given for 12 weeks as an induction therapy. Maintenance treatment consisted of interferon-alp

Intensive chemotherapy induction followe
Intensive chemotherapy induction followed by interferon-alpha maintenance in patients with Philadelphia chromosome-positive chronic myelogenous leukemia
✍ Hagop M. Kantarjian; Moshe Talpaz; Michael J. Keating; Elihu H. Estey; Susan O'b πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 585 KB

In a pilot study, 32 patients with Philadelphia chromosome-positive chronic myelogenous leukemia were treated with intensive chemotherapy induction followed by interferon-alpha (IFN-A) maintenance. Intensive chemotherapy consisted of three cycles of daunorubicin 120 mg/mz on day 1, cytarabine 80 mg/